Education
About Us
Working with TipRanks
Follow Us
New Portfolio - New Portfolio
BioBudha
New PortfolioIndividual Investor
Not Ranked
Ranked #― out of 1 TipRanks' Investors
Success Rate
295 out of 678
profitable transactions
profitable transactions
Average Return
4.36%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 1.90%
6-Month Return▲ 14.72%
12-Month Return▲ 33.58%
YTD Return▲ 35.29%
Total Return▲ 113.37%
Best Trade
Bio
I am an recent individual investor, exploring, learning and refining my investment skills
Performance
13.12%0-13.12%
▲ 11.63%
▲ 6.28%
▲ 13.12%
May 2025
▲ 9.25%
▲ 5.14%
▲ 6.15%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 6.50%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 1.02%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.89%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 0.62%
Oct 2025
▼ 3.57%
▲ 0.19%
▼ 4.49%
Nov 2025
▲ 1.55%
▲ 1.31%
▲ 1.90%
Dec 2025
▲ 11.63%▲ 6.28%▲ 13.12%
▲ 9.25%▲ 5.14%▲ 6.15%
▲ 7.60%▲ 2.30%▲ 6.50%
▲ 2.76%▲ 2.05%▲ 1.02%
▲ 12.88%▲ 3.56%▲ 8.89%
▲ 10.96%▲ 2.38%▲ 0.62%
▼ 3.57%▲ 0.19%▼ 4.49%
▲ 1.55%▲ 1.31%▲ 1.90%
Recent Activity
POET Technologies
―
▼ 7.58%
2
Close
Sep 27, 2024
Palantir Technologies
14.12%
▲ 467.12%
2
Buy
Sep 24, 2024
Schwab US Dividend Equity ETF
8.07%
▲ 1.87%
6
Buy
Sep 24, 2024
Tesla
5.03%
▲ 34.12%
6
Buy
Sep 24, 2024
Meta Platforms
4.81%
▲ 17.28%
2
Buy
Sep 24, 2024
Vanguard S&P 500 Growth ETF
9.57%
▲ 31.58%
2
Buy
Sep 24, 2024
Vanguard Growth ETF
3.6%
▲ 29.65%
2
Buy
Sep 24, 2024
Nvidia
19.24%
▲ 55.78%
1
Open
Sep 24, 2024
Roblox
1.79%
▲ 73.04%
1
Open
Sep 24, 2024
Hookipa Pharma
―
▼ 95.79%
16
Close
Sep 23, 2024
Roundhill Sports Betting & iGaming ETF
―
▼ 36.76%
4
Close
Sep 23, 2024
ARK Fintech Innovation ETF
―
▼ 18.97%
14
Close
Sep 23, 2024
ARK Innovation ETF
―
▼ 17.89%
26
Close
Sep 23, 2024
ARK Space Exploration & Innovation ETF
―
▼ 23.96%
2
Close
Sep 23, 2024
Replimune Group
―
▼ 23.09%
8
Close
Sep 23, 2024
Invesco WilderHill Clean Energy ETF
―
▼ 24.44%
6
Close
Sep 23, 2024
Curis
―
▼ 96.45%
7
Close
Sep 23, 2024
Skillz
―
▼ 99.11%
2
Close
Sep 23, 2024
Scholar Rock Holding
―
▼ 80.83%
7
Close
Sep 23, 2024
Adaptimmune Therapeutics
―
▼ 82.73%
2
Close
Sep 23, 2024